Techniques disclosed herein relate to infusion devices and related meal bolus adjustment methods. In some embodiments, the techniques may involve determining an initial bolus amount. The techniques may further involve predicting a value for a first physiological condition based at least in part on the initial bolus amount. The techniques may further involve when the predicted value for the first physiological condition violates a threshold: identifying an adjusted bolus amount that results in the predicted value for the first physiological condition satisfying the threshold, and causing delivery of the adjusted bolus amount.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
2.
PERSISTENT HEALTH MONITORING OF A PATIENT BY A MEDICAL SYSTEM INVOKING AN APPLICATION RESTART
This disclosure is directed to medical systems and techniques for enhanced health monitoring using location information. In one example, a method performed by processing circuitry of a computing device is described. The method comprises: determining that a monitoring application, previously executed by the processing circuitry, is inoperative; receiving, from an input device of the computing device, input data indicative of a current location of a patient; determining whether the current location of the patient corresponds to an authenticated area of the patient; and in response to the determination that the current location corresponds to the authenticated area and to the determination that the monitoring application is inoperative, restarting the monitoring application.
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G06F 9/44 - Arrangements for executing specific programs
G06F 11/07 - Responding to the occurrence of a fault, e.g. fault tolerance
G06F 11/14 - Error detection or correction of the data by redundancy in operation, e.g. by using different operation sequences leading to the same result
H04W 4/021 - Services related to particular areas, e.g. point of interest [POI] services, venue services or geofences
3.
STIMULATION THERAPY FOR TREATING OBSTRUCTIVE SLEEP APNEA (OSA) BASED ON COMPOUND MUSCLE ACTION POTENTIAL (CMAP)
A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.
Disclosed is a system to engage a plurality of tools. In the system a drive shaft and collet may be assembled to engage and disengage, selectively, a plurality of tools. User selection may allow use of a plurality of tools during a procedure or during a plurality of procedures.
Aspects of the disclosure relate to pledget stimulation/recording electrode assemblies that are particularly useful for automatic periodic stimulation. Embodiments are compatible with nerve monitoring systems to provide continuous stimulation of a nerve during surgery. Disclosed embodiments include an electrode assembly having one or more electrodes rotatably supported by and positioned within a pledget substrate. The flexible pledget substrate conforms and fixates to bioelectric tissue to secure the electrode assembly in position, wrapped around the target tissue. In some embodiments, the pledget substrate includes two bodies, each including at least one electrode, the two bodies being selectively separable so that the bodies can be repositioned with respect to one another. The electrode assembly further includes a lead wire assembly including at least one insulating jacket positioned around a wire core. Optionally, the electrode assembly includes an insulating cup interconnecting the electrode and the insulating jacket.
Systems, instruments, and methods for surgical navigation with verification feedback are provided. The systems, instruments, and methods may be used to verify a trajectory of a surgical tool during a procedure. The systems, instruments, and methods may receive one or more captured images of an anatomical portion of a patient; execute a surgical plan to insert the surgical tool into the anatomical portion; receive sensor data collected from one or more sensors being inserted into the anatomical portion; determine whether the sensor data corresponds to the surgical plan; and send, in response to determining that the sensor data does not correspond to the surgical plan, an alert indicating that the surgical tool is not being inserted according to the surgical plan. The one or more sensors may be attached to the surgical tool.
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
A61B 17/16 - Osteoclasts; Drills or chisels for bones; Trepans
7.
LEAD INTEGRITY AND CLOSED-LOOP ALGORITHM DIAGNOSTIC
In one example, the disclosure describes a method comprising receiving, by processing circuitry, information indicative of one or more evoked compound action potential (ECAP) signals. The one or more ECAP signals are sensed by at least one electrode carried by a medical lead. The processing circuitry determining that at least one characteristic value of the one or more ECAP signals is outside of an expected range. Responsive to determining that the at least one characteristic value of the one or more ECAP signals is outside of the expected range, the processing circuitry performs a lead integrity test for the medical lead.
A medical system for obstructive sleep apnea (OSA) treatment includes therapy delivery circuitry configured to output one or more electrical stimulation signals to a tongue of a patient; sensing circuitry configured to sense one or more compound muscle action potential (CMAP) signals, wherein the one or more CMAP signals are generated in response to the delivery of the one or more electrical stimulation signals; and processing circuitry configured to: cause the therapy delivery circuitry to output the one or more electrical stimulation signals to the tongue; receive information indicative of the one or more CMAP signals from the sensing circuitry; determine, based on the one or more CMAP signals, one or more therapeutic stimulation parameters for the OSA treatment; and cause the therapy delivery circuitry to deliver therapeutic electrical stimulation signals according to at least the determined one or more therapeutic stimulation parameters.
Computer implemented methods of producing a bone graft are provided. These methods include obtaining a 3-D image of an intended bone graft site; generating a 3-D digital model of the bone graft based on the 3-D image of the intended bone graft site, the 3-D digital model of the bone graft being configured to fit within a 3-D digital model of the intended bone graft site; storing the 3-D digital model on a database coupled to a processor, the processor having instructions for retrieving the stored 3-D digital model of the bone graft and for combining a carrier material with, in or on a bone material based on the stored 3-D digital model and for instructing a 3-D printer to produce the bone graft. A layered 3-D printed bone graft prepared by the computer implemented method is also provided.
A system for sensing physiological traits of a maternal patient and a fetal patient carried by the maternal patient during a pregnancy using one or more sensors. The system may use the physiological traits sensed to define a maternal attribute for the maternal patient and a fetal attribute for the fetal patient, such as a heart rate, blood pressure, respiration rate, temperature, oxygen saturation level, or other attributes. The system is configured to compare the maternal attribute to a maternal limit describing a threshold for the maternal patient and/or compare the fetal attribute to a fetal limit describing a threshold for the fetal patient. The system is configured to issue a communication to the maternal patient and/or a clinician based on the comparisons. In examples, the system regularly communicates the maternal attribute and/or the fetal attribute to an output device of the maternal patient and/or a clinician.
A61B 5/0205 - Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using optical sensors, e.g. spectral photometrical oximeters
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/28 - Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
A61B 5/296 - Bioelectric electrodes therefor specially adapted for particular uses for electromyography [EMG]
A61B 5/1464 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using optical sensors, e.g. spectral photometrical oximeters specially adapted for foetal tissue
An extra-cardiovascular medical device is configured to select a capacitor configuration from a capacitor array and deliver a low voltage, pacing pulse by discharging the selected capacitor configuration across an extra-cardiovascular pacing electrode vector. In some examples, the medical device is configured to determine the capacitor configuration based on a measured impedance of the extra-cardiovascular pacing electrode vector.
An implantable medical device includes a plurality of electrodes to detect electrical activity, a motion detector to detect mechanical activity, and a controller to determine at least one electromechanical interval based on at least one of electrical activity and mechanical activity. The activity detected may be in response to delivering a pacing pulse according to an atrioventricular (AV) pacing interval using the second electrode. The electromechanical interval may be used to adjust the AV pacing interval. The electromechanical interval may be used to determine whether cardiac therapy is acceptable or whether atrial or ventricular remodeling is successful.
A61N 1/368 - Heart stimulators controlled by a physiological parameter, e.g. by heart potential comprising more than one electrode co-operating with different heart regions
An interbody system including an implant and a tool for inserting and expanding the medical implant and locking the implant in place is disclosed. The medical implant may include an expandable body defined by a superior endplate and an inferior endplate that are hingedly coupled and may be expanded and lordosed. The superior and inferior endplate may include gripping protrusions that mate and/or directly engage with recessed jaws of disclosed surgical tool. The surgical tool may include a vertically movable jaw to expand and contract the implant when engaged with the gripping protrusions of the implant. The surgical tool may also include a drive portion that engages the drive feature of the lock screw with the drive end of the surgical tool lock the implant while in an expanded position.
A medical device is configured to obtain an impedance measurement and determine that a medical lead received by a connector bore of the medical device is either an integrated bipolar lead or a true bipolar lead based on the impedance measurement. The medical device is configured to select at least one operating parameter setting based on the determined medical lead type and process a cardiac electrical signal received via the medical lead according to the at least one operating parameter setting for determining a need for an electrical stimulation therapy.
An implantable medical device (IMD) including an insulating frame defining a drop-in coil channel adjacent a perimeter of the insulating frame, a rechargeable power source configured to supply power for the implantable medical device, a secondary coil including a first and a second wire end, where the secondary coil is received within the drop-in coil channel and is configured to inductively couple with a primary coil of an external charging device to transcutaneously charge the rechargeable power source. The IMD also includes a circuit board attached to the insulating frame and a pair of electrical connectors each having a respective first arm that is electrically coupled to the respective first and second wire ends of the secondary coil and respective second arm that is electrically coupled to the circuit board.
A system for sensing one or more physiological traits and obstetric conditions, such as a fertility phase, pregnancy, labor, post-partum conditions, and other conditions related to the reproductive system of the patient. The system may use the one or more physiological traits sensed to define one or more patient attributes for the patient, such as a hormone level, heart rate, blood pressure, respiration rate, temperature, oxygen saturation level, uterine contractions, fluid level, and/or other patient attributes. The system is configured to compare the one or more patient attributes to one or more attribute signs describing a threshold for the one or more patient attributes. The system is configured to issue a communication to the patient and/or a clinician based on the comparisons. The system may be configured to assess and indicate reproductive phases for the patient over a life-cycle from the fertility phase to the post-partum phase.
A61B 5/0205 - Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using optical sensors, e.g. spectral photometrical oximeters
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/0537 - Measuring body composition by impedance, e.g. tissue hydration or fat content
A61B 5/28 - Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
A61B 5/296 - Bioelectric electrodes therefor specially adapted for particular uses for electromyography [EMG]
A61B 10/00 - Other methods or instruments for diagnosis, e.g. for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
17.
RESORBABLE, DRUG-ELUTING SUBMUCOSAL TURBINATE IMPLANT DEVICE AND METHOD
Implants are placed in turbinate mucosal tissue using a surgical device having a proximal grip portion and a distal hollow sharp needle portion that is manipulated using the grip portion and inserted submucosally into mucosal turbinate tissue. One or more biodegradable, drug-eluting solid implants are disposed within the needle. The implants have one or more implant withdrawal-discouraging, mucosal tissue-engaging surface features along their length. An actuator disposed within the device is used to deliver one or more of the implants from the needle into the mucosal turbinate tissue and submucosally bury at least one such tissue-engaging feature therein.
A61M 5/32 - Syringes - Details - Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
A61K 9/00 - Medicinal preparations characterised by special physical form
A61L 31/16 - Biologically active materials, e.g. therapeutic substances
A61B 17/24 - Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
18.
METHODS AND SYSTEMS FOR UPDATING MODELS USED FOR ESTIMATING GLUCOSE VALUES
Methods, systems and non-transient computer-readable media are provided for updating models used for estimating glucose values. For example, technologies are provided for updating an existing population model for estimating glucose values for a population of users to generate a new updated population model for a subset of users of the population of users. As another example, technologies are provided for updating an existing personalized model for estimating glucose values to generate a new updated personalized model that is personalized for a particular user.
G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
19.
IMPLANTABLE APAPRATUS HAVING MARKERS FOR DETERMINING PENETRATION DEPTH
An implantable apparatus (100) and methods thereof. The implantable apparatus (100) includes a body (110) defining a distal end region (112) extending along a distal end region axis (111). The body (110) is configured to be inserted into cardiac tissue of a patient's heart at a target site. The implantable apparatus (100) also includes a plurality of markers (120) located along at least a portion of an outer surface of the distal end region (112) of the body (110). The plurality of markers (120) define a first configuration when located within the cardiac tissue and a second configuration when not located within the cardiac tissue. The first configuration is different than the second configuration.
Systems, devices, and techniques are described for calibrating a medical device that senses ECAP signals from a patient's nerve tissue. For example a method includes: instructing, with processing circuitry, stimulation circuitry of a medical device to deliver, on stimulation electrodes of the medical device, an electrical stimulation signal having an amplitude substantially equal to zero to a patient; entering, with the processing circuitry subsequent to instructing the stimulation circuitry to deliver the electrical stimulation signal, a passive recharge state on stimulation electrode circuitry; and auto-zeroing, with the processing circuitry, inputs to an operational amplifier of sensing circuitry electrically coupled to sensing electrodes of the medical device while the stimulation electrode circuitry is in the passive recharge state.
Systems, devices, and techniques are described for calibrating a medical device that senses ECAP signals from a patient's nerve tissue. For example a method includes: instructing, with processing circuitry, stimulation circuitry of a medical device to deliver, on stimulation electrodes of the medical device, an electrical stimulation signal having an amplitude substantially equal to zero to a patient; entering, with the processing circuitry subsequent to instructing the stimulation circuitry to deliver the electrical stimulation signal, a passive recharge state on stimulation electrode circuitry; and auto-zeroing, with the processing circuitry, inputs to an operational amplifier of sensing circuitry electrically coupled to sensing electrodes of the medical device while the stimulation electrode circuitry is in the passive recharge state.
A device, such as an IMD, having a tissue conductance communication (TCC) transmitter controls a drive signal circuit and a polarity switching circuit by a controller of the TCC transmitter to generate an alternating current (AC) ramp on signal having a peak amplitude that is stepped up from a starting peak-to-peak amplitude to an ending peak-to-peak amplitude according to a step increment and step up interval. The TCC transmitter is further controlled to transmit the AC ramp on signal from the drive signal circuit and the polarity switching circuit via a coupling capacitor coupled to a transmitting electrode vector coupleable to the IMD. After the AC ramp on signal, the TCC transmitter transmits at least one TCC signal to a receiving device.
Techniques are disclosed for using feature delineation to reduce the impact of machine learning cardiac arrhythmia detection on power consumption of medical devices. In one example, a medical device performs feature-based delineation of cardiac electrogram data sensed from a patient to obtain cardiac features indicative of an episode of arrhythmia in the patient. The medical device determines whether the cardiac features satisfy threshold criteria for application of a machine learning model for verifying the feature-based delineation of the cardiac electrogram data. In response to determining that the cardiac features satisfy the threshold criteria, the medical device applies the machine learning model to the sensed cardiac electrogram data to verify that the episode of arrhythmia has occurred or determine a classification of the episode of arrhythmia.
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
Systems, devices and methods are disclosed for a prescription-regulated software application and an associated medical device. In some aspects, a smart medicine-injection device (e.g., smart insulin pen) is configured to be in communication with a patient's companion device (e.g., smartphone) having a software application (prescription app) that serves the patient as a complimentary medical device to the smart medicine-injection device, in which only certain features and functionalities of the prescription app are fully operable based on device pairing with the smart medicine-injection device to unlock medical device capabilities only available to the patient through prescription.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A method for determining a pressure gradient between proximal and distal locations within a vasculature of a patient. The method includes deploying an ancillary device within the vasculature. The ancillary device integrates a proximal sensor at the proximal location and a distal sensor at the distal location. The method further includes deploying, via a stent graft delivery system, a stent graft within the vasculature to obtain a deployed stent graft. The ancillary device is independent from the stent graft delivery system and the stent graft. The method further includes outputting proximal pressure data from the proximal sensor and indicative of pressure at the proximal location and distal pressure data from the distal sensor and indicative of pressure at the distal location. The method also includes determining the pressure gradient using the proximal and distal pressure data.
An example implantable medical lead includes a first defibrillation electrode and a second, defibrillation electrode, the first and second, defibrillation electrodes configured to deliver first electrical therapy. Tire implantable medical lead also includes a. pace electrode disposed longitudinally between the first defibrillation electrode and die second defibrillation electrode, the pace electrode configured to deliver second electrical therapy comprising pacing pulses. The implantable medical lead further includes a shield disposed over a portion of an outer surface of the pace electrode and extending laterally away from the pace electrode, wherein the shield comprises an asymmetric shape about a longitudinal axis of the shield, wherein die shield is configured to impede an electric field of at least one of the first and second electrical therapies in a direction away from a. heart of the patient.
A method and medical device for detecting a cardiac event that includes sensing cardiac signals from a plurality of electrodes, the plurality of electrodes forming a first sensing vector and a second sensing vector, identifying the cardiac event as one of a shockable event and a non-shockable event in response to first processing of a first interval sensed along the first sensing vector during a predetermined sensing window and a second interval simultaneously sensed along the second sensing vector, performing second processing of the first interval and the second interval, different from the first processing, in response to the cardiac event being identified as a shockable event, and determining whether to delay identifying the cardiac event being shockable in response to the second processing of the first interval and the second interval.
Systems, devices, and methods may be used to deliver and provide cardiac pacing therapy to a patient. Leads or leadlets carrying one or more left ventricular electrodes may be positioned in or near the interventricular septum to sense and pace left ventricular signals of the patient's heart. In one example, a leadlet including one or more left ventricular electrodes may extend in the coronary sinus from a leadless implantable medical device located in the right atrium.
A61N 1/368 - Heart stimulators controlled by a physiological parameter, e.g. by heart potential comprising more than one electrode co-operating with different heart regions
A61N 1/05 - Electrodes for implantation or insertion into the body, e.g. heart electrode
An implantable medical device system is configured to detect a tachyarrhythmia from a cardiac electrical signal and start an ATP therapy delay period. The implantable medical device determines whether the cardiac electrical signal received during the ATP therapy delay period satisfies ATP delivery criteria. A therapy delivery module is controlled to cancel the delayed ATP therapy if the ATP delivery criteria are not met and deliver the delayed ATP therapy if the ATP delivery criteria are met.
Disclosed herein are techniques related to safeguards against separation from portable medicine delivery devices. In some embodiments, the techniques may involve monitoring a wireless connection established between a portable computing device and a portable medicine delivery device. The techniques may also involve making a determination, based on the result of the monitoring, that the portable medicine delivery device is outside a predetermined range of the portable computing device. The techniques may further involve generating a notification based on the determination. The notification may be indicative of a user of the portable computing device being unaccompanied by the portable medicine delivery device.
Disclosed herein are techniques related to safeguards against usage of incorrect portable medicine delivery devices. Such techniques may be practiced for a plurality of portable medicine delivery devices that include a first device and a second device. The techniques may involve obtaining usage data indicative of the first device being manipulated in preparation for medicine delivery. The techniques may further involve determining, based on the usage data, that the first device is mistakenly being manipulated instead of the second device. The technique may also involve, responsive to determining that the first device is mistakenly being manipulated, generating a message to prevent medicine delivery by the first device.
A61M 5/315 - Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod; Appliances on the rod for facilitating dosing
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
An implantable medical lead includes a first defibrillation electrode and a second defibrillation electrode. The implantable medical lead further includes a pacing electrode configured to deliver a pacing pulse that generates an electric field proximate to the pacing electrode. The implantable medical lead further includes a shield disposed over a portion of an outer surface of the pacing electrode and extending laterally away from the pacing electrode. The shield is configured to impede the electric field in a direction from the pacing electrode away from a heart. The implantable medical lead further includes a conductive surface disposed on the shield and electrically coupled to the pacing electrode.
An example impkintable medical lead includes a first defibrillation electrode and a second, defibrillation electrode, the first and second, defibrillation electrodes configured to deliver first electrical therapy comprising anti tachyarrhythmia shocks. The implantable medical lead also includes a pace electrode disposed longitudinally between the first defibrillation electrode and the second defibrillation electrode, the pace electrode configured to deliver a pacing pulse that generates an electric field proximate to the pace electrode. The implantable medical lead further includes an inflatable shield disposed over a portion of an outer surface of the pace electrode, wherein the inflatable shield is configured to extend laterally away from the pace electrode upon inflation, wherein the inflatable shield is configured to impede an electric field of at least, one of the first and second the electrical therapies in a direction away from a heart of the patient.
Disclosed herein are techniques related to automatic real-time meal detection. In some embodiments, the techniques involve obtaining a plurality of glucose concentration values and a plurality of plasma insulin concentration estimations, each glucose concentration value corresponding with a respective plasma insulin concentration estimation; generating an output based on applying a meal detection model to the plurality of glucose concentration values and the plurality of plasma insulin concentration estimations; and determining, based on the output, that a glucose concentration value of the plurality of glucose concentration values corresponds to an ongoing glycemic response to a meal.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value using enzyme electrodes, e.g. with immobilised oxidase
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
36.
CONTINUOUS ANALYTE SENSOR QUALITY MEASURES AND RELATED THERAPY ACTIONS FOR AN AUTOMATED THERAPY DELIVERY SYSTEM
Techniques disclosed herein relate to continuous analyte sensor quality measures. In some embodiments, the techniques may involve obtaining a current sensor-generated value that is indicative of a physiological characteristic of a user of a medical device, the current sensor-generated value produced in response to operation of a continuous analyte sensor device. The techniques may further involve obtaining a sensor quality metric that indicates accuracy of the current sensor-generated value. The techniques may further involve causing, in response to obtaining the sensor quality metric, configuration of a quality-specific operating mode of the medical device, the quality-specific operating mode comprising separate regulation of basal and bolus deliveries of a fluid medication based on the obtained sensor quality metric. The techniques may further involve causing regulation of fluid medication delivery from the medical device, in accordance with the current sensor-generated value and the quality-specific operating mode of the medical device.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
37.
SYSTEMS, METHODS, AND DEVICES FOR RECONSTRUCTING A THREE-DIMENSIONAL REPRESENTATION
Systems, methods, and devices for reconstructing an image is provided. An imaging device may be oriented at one or more poses and an image may be received at each of the one or more poses to form a set of images. Pose information may be received at each of the one or more poses. The set of images and the pose information may be inputted into a reconstruction model to generate a three-dimensional representation of the one or more anatomical elements.
A medical device comprising an elongate body having a proximal portion, a distal portion, a distal end, a longitudinal axis, and a radius, a plurality of deployable arms, the deployable arms being movably coupled to the elongate body, and at least one arm from the plurality of deployable arms having at least one electrically conductive surface. The plurality of deployable arms being movable from a collapsed configuration to an expanded configuration. In the collapsed configuration, the plurality of deployable arms are approximately parallel to the longitudinal axis. In the expanded configuration, the at least one electrically conductive surface is distal facing and is positioned radially from the longitudinal axis by a distance that is greater than the radius of the elongate body.
Devices, systems, and techniques are disclosed for delivering electric field therapy to tissue of a subject. In one example, medical lead comprises a housing, one or more structures coupled to the housing, and a plurality of electrodes disposed on the one or more structures and configured to deliver electrical fields, wherein the one or more structures are configured to position the plurality of electrodes with respect to a tissue resection region.
A system for extracting a transvenous endocardial lead includes a lead extender with a collet configured to releasably engage a pin of a connector on the lead, and a locking ring configured to maintain the engagement of the collet on the pin of the connector. The system further includes a lead extraction sheath having a sheath body with a tapered distal region, wherein a wall of the tapered distal region and a wall of the sheath body include an arrangement of openings configured to allow insertion of the lead extender and a body of the endocardial lead.
A method of detecting hypertension in a patient having an implantable blood pump, the method includes operating the implantable blood pump at a first pump set speed during a first period of time. A first flow rate minimum during a cardiac cycle of the patient is measured. during the first period of time. The first pump set speed is reduced by at least 200 rpm during a second period of time after the first period of time to a second pump set speed, the second period of time being less than the first period of time. A second flow rate minimum is measured during a cardiac cycle during the second period of time. If the second flow rate minimum decreases during the second period of time at the second pump set speed by more than a predetermined amount, an alert is generated indicating a presence of hypertension.
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/029 - Measuring blood output from the heart, e.g. minute volume
A61M 60/178 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable in, on, or around the heart drawing blood from a ventricle and returning the blood to the arterial system via a cannula external to the ventricle, e.g. left or right ventricular assist devices
A61M 60/562 - Electronic control means, e.g. for feedback regulation for making blood flow pulsatile in blood pumps that do not intrinsically create pulsatile flow
A61M 60/422 - Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance - Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being electromagnetic, e.g. using canned motor pumps
A61M 60/148 - Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient’s body implantable via, into, inside, in line, branching on, or around a blood vessel in line with a blood vessel using resection or like techniques, e.g. permanent endovascular heart assist devices
A61M 60/538 - Regulation using real-time blood pump operational parameter data, e.g. motor current
A61M 60/531 - Regulation using real-time patient data using blood pressure data, e.g. from blood pressure sensors
A61M 60/237 - Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
42.
FLUID DELIVERY ADJUSTMENTS BASED ON PREDICTED PHYSIOLOGICAL CONDITIONS
Techniques disclosed herein relate to operating a fluid delivery device in a personalized manner based at least in part on historical data of a patient. In some embodiments, the techniques involve determining a predicted physiological condition of a patient in response to a future activity of the patient, based at least in part on historical data corresponding to the future activity for the patient; determining, based at least in part on the predicted physiological condition of the patient, an adjustment to fluid delivery to the patient by a medical device to prospectively account for the future activity; and operating the medical device to deliver a fluid to the patient in accordance with the adjustment.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 10/20 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
Devices, systems, and techniques are disclosed for planning, updating, and delivering electric field therapy. In one example, a system comprises processing circuitry configured to receive a request to deliver alternating electric field (AEF) therapy and determine therapy parameter values that define the AEF therapy, wherein the AEF therapy comprises delivery of a first electric field and a second electric field. The processing circuitry may also be configured to control an implantable medical device to deliver the first electric field from a first electrode combination of implanted, electrodes and control the implantable medical device to deliver, alternating with the first electric field, the second electric field from a second electrode combination of implanted electrodes different than the first electrode combination.
A medical device is configured to deliver a cardiac pacing pulse by enabling a bypass circuit to couple a cardiac pacing voltage source to a cardiac pacing output pathway that excludes a first portion of a high voltage output circuit used to deliver cardioversion/defibrillation shock pulses by the medical device and includes a second portion of the high voltage output circuit used for delivering cardioversion/defibrillation shock pulses.
A surgical system for adjusting a segment of a spine is disclosed. The system may include a rack arm extending in a longitudinal direction from a first end to a second end, and a sliding body portion including a ratcheting mechanism selectively engageable with a spline portion of the rack arm. The system may include a first actuator for translating the sliding body along the rack arm in the longitudinal direction. The system may include a first and second connection tower extending along a first and second axis, respectively, that are each transverse to the longitudinal direction. The system may further include a second actuator including a threaded screw for adjusting the first connection tower along a first axis. In some embodiments, the second actuator is configured to raise and lower the first connection tower in a sagittal plane.
Ambulatory infusion pumps, medicament reservoirs, and medicament sealing assemblies, including a variety of trocar seal assemblies and fill plug seal assemblies, plus related components, as well as component combinations and related methods.
Systems and methods for determining modified fractional flow reserve values of vascular lesions are provided. Patient physiologic data, including coronary vascular information, is measured. According to the physiologic data, a coronary vascular model is generated. Lesions of interest within the coronary vascular system of the patient are identified for modified fractional flow reserve value determination. The coronary vascular model is modified to generate modified blood flow information for determining the modified fractional flow reserve value.
In some examples, a prosthetic device is configured to expand radially outward to position a valve assembly to control blood flow through an annulus of a heart valve. The prosthetic device supports a plurality of imaging markers around a perimeter defined by the prosthetic device. In examples, the prosthetic device includes an anchoring member configured to expand to engage the annulus of the heart valve. In examples, the anchoring member defines the perimeter. The prosthetic device may support the imaging markers to radially extend inwards and/or laterally extend in an upstream and/or downstream direction of the prosthetic device to displace the imaging markers from tissues within the heart when the prosthetic device engages the annulus of the heart valve.
A relatively compact implantable medical device includes a fixation member formed by a plurality of fingers mounted around a perimeter of a distal end of a housing of the device; each finger is elastically deformable from a relaxed condition to an extended condition, to accommodate delivery of the device to a target implant site, and from the relaxed condition to a compressed condition, to accommodate wedging of the fingers between opposing tissue surfaces at the target implant site, wherein the compressed fingers hold a cardiac pacing electrode of the device in intimate tissue contact for the delivery of pacing stimulation to the site. Each fixation finger is preferably configured to prevent penetration thereof within the tissue when the fingers are compressed and wedged between the opposing tissue surfaces. The pacing electrode may be mounted on a pacing extension, which extends distally from the distal end of the device housing.
An intracardiac ventricular pacemaker is configured to operate in in a selected one of an atrial-tracking ventricular pacing mode and a non-atrial tracking ventricular pacing mode. A control circuit of the pacemaker determines at least one motion signal metric from the motion signal, compares the at least one motion signal metric to pacing mode switching criteria, and, responsive to the pacing mode switching criteria being satisfied, switches from the selected one of the non-atrial tracking pacing mode and the atrial tracking pacing mode to the other one of the non-atrial tracking pacing mode and the atrial tracking pacing mode for controlling ventricular pacing pulses delivered by the pacemaker.
A61N 1/365 - Heart stimulators controlled by a physiological parameter, e.g. by heart potential
A61N 1/375 - Constructional arrangements, e.g. casings
A61N 1/368 - Heart stimulators controlled by a physiological parameter, e.g. by heart potential comprising more than one electrode co-operating with different heart regions
51.
FIXATION COMPONENT FOR MULTI-ELECTRODE IMPLANTABLE MEDICAL DEVICE
An example fixation component for an implantable medical device (IMD) includes a base and tines extending from the base and being spaced apart from one another. The tines include a penetrator tine and a protector tine. The penetrator tine includes a curved section defining a deformable preset curvature that extends laterally from a proximal section that is fixed to the base, traversing a longitudinal axis of the fixation component, to a distal section that terminates in an incisive distal end that is configured to penetrate a tissue to form a puncture. The protector tine includes a curved section defining a deformable preset curvature that extends from a proximal section that is fixed to the base, outward from the longitudinal axis, to a distal section that terminates in a non-incisive distal end that is configured to pass through the puncture.
Disclosed is a localizer system. The localizer system may be incorporated into a navigation system for tracking a tracking device. Generally, the localizer may include a transmitting coil array and a field shaping assembly.
A61B 34/20 - Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
G01R 33/02 - Measuring direction or magnitude of magnetic fields or magnetic flux
A61B 5/06 - Devices, other than using radiation, for detecting or locating foreign bodies
G01D 5/20 - Mechanical means for transferring the output of a sensing member; Means for converting the output of a sensing member to another variable where the form or nature of the sensing member does not constrain the means for converting; Transducers not specially adapted for a specific variable using electric or magnetic means influencing the magnitude of a current or voltage by varying inductance, e.g. by a movable armature
A surgical instrument includes a first member defining an axis and including a cutting surface. A second member includes a cutting surface that is rotatable relative to the first member. A third member includes an outer surface. The cutting surface of the second member is rotatable relative to the outer surface to transfer the cut tissue along the axis. Systems and methods are disclosed.
In some embodiments, a prosthetic heart valve delivery device is provided that includes an outer shaft received over an inner shaft, and rod. The rod is selectively inserted or advanced along a slot in the outer shaft to increase a torqueability of the outer shaft. In some embodiments, a prosthetic heart valve delivery device is provided that includes a handle assembly, an outer shaft received over an inner shaft, a stability shaft received over the outer shaft, and a wire. A leading section of the wire is affixed to the stability shaft, and a trailing section of the wire extends proximally from the stability shaft and is selectively engaged by a locking mechanism of the handle assembly. In a locked state of the locking mechanism, tension is maintained in the wire and generates a bending stiffness in the stability shaft.
A system for providing therapy to a patient includes stimulation generation circuitry, sensing circuitry, and processing circuitry. The processing circuitry is configured to cause storage of a first voltage at a first terminal at a first calibration capacitor and storage of a second voltage at a second terminal at a second calibration capacitor. The processing circuitry is configured to switch out a first calibration switch to prevent the first voltage stored at the first calibration capacitor from changing and switch out a second calibration switch to prevent the second voltage stored at the second calibration capacitor from changing and determine, with the sensing circuitry, a sensing signal based on the first voltage offset by a first calibration voltage stored by the first capacitor and based on the second voltage offset by a second calibration voltage stored by the second capacitor.
An example device of a patient includes an antenna configured to wirelessly receive communication from a medical device; and processing circuitry coupled to the antenna and configured to: determine that the received communication indicates that a patient is experiencing an acute health event; in response to the determination, determine one or more physical states of the patient based on sensed data from one or more sensors; confirm that the patient is not experiencing the acute health event based on the determined one or more physical states; and output information based on the confirmation that the patient is not experiencing the acute health event.
Techniques related to classifying a posture state of a living body are disclosed. One aspect relates to sensing at least one signal indicative of a posture state of a living body. Posture state detection logic classifies the living body as being in a posture state based on the at least one signal, wherein this classification may take into account at least one of posture and activity state of the living body. The posture state detection logic further determines whether the living body is classified in the posture state for at least a predetermined period of time. Response logic is described that initiates a response as a result of the body being classified in the posture state only after the living body has maintained the classified posture state for at least the predetermined period of time. This response may involve a change in therapy, such as neurostimulation therapy, that is delivered to the living body.
A medical device comprises a sensing circuit configured to sense at least one cardiac electrical signal, sense first ventricular event signals from the at least one cardiac electrical signal according to a sensitivity setting set to a first amplitude; and a control circuit in communication with the sensing circuit, the control circuit configured to determine that the at least one cardiac electrical signal meets suspected undersensing criteria, in response to determining that the suspected undersensing criteria are met, perform a morphology analysis of a first cardiac signal segment acquired from a first cardiac electrical signal of the at least one cardiac electrical signal sensed by the sensing circuit over a first predetermined time interval, determine that the first cardiac signal segment is a first tachyarrhythmia segment based on the morphology analysis, and adjust the sensitivity setting from the first amplitude to a second amplitude less than the first amplitude in response to determining that the first cardiac signal segment is a first tachyarrhythmia segment.
A method for determining a depth of discharge of an electrochemical cell includes (i)) providing one or more alkaline electrochemical cells comprising Ag2O-Zn; (ii) applying a varying voltage potential to the one or more alkaline electrochemical cells, (iii) measuring an output current response of the one or more alkaline electrochemical cells, the output current response comprising a phase response as a function of frequency; and (iv) determining a depth of discharge of the one or more alkaline electrochemical cells based on a linear relationship of the depth of discharge with the phase response.
H01M 6/50 - Methods or arrangements for servicing or maintenance, e.g. for maintaining operating temperature
G01R 31/389 - Measuring internal impedance, internal conductance or related variables
H01M 50/109 - Primary casings, jackets or wrappings of a single cell or a single battery characterised by their shape or physical structure of button or coin shape
62.
CARDIAC PROSTHESIS DELIVERY DEVICE HAVING DEVICE POSITION FEEDBACK
Delivery devices for delivering a cardiac prosthesis to a target site are disclosed. Such devices can be used with a feedback system including haptic elements incorporated into the delivery device for providing tactile and/or audio feedback regarding the loading and/or deployment of the prosthesis. Certain disclosed delivery devices include a handle including an actuator, a sheath interconnected to the handle for selectively sheathing the prosthesis. The feedback system can be provided within the handle and configured to provide one or more feedback indications relating to the position of the sheath with respect to the prosthesis during loading and/or deployment of the prosthesis.
A medical device having a motion sensor is configured to sense a motion signal, generate ventricular pacing pulses in a non-atrial tracking ventricular pacing mode and detect atrial event signals from the motion signal during the non-atrial tracking ventricular pacing mode. The medical device may be configured to determine atrial event intervals from the detected atrial event signals, determine a frequency distribution of the determined atrial event intervals and determine an atrial rate based on the frequency distribution of the detected atrial event intervals.
A transcatheter valve prosthesis includes a stent and a prosthetic valve. The prosthetic valve is configured to substantially block blood flow in one direction to regulate blood flow through a central lumen of the stent. The stent includes an inflow portion, an outflow portion, and a transition portion extending between the inflow portion and the outflow portion. The transition portion includes a plurality of axial frame members extending between the inflow portion and the outflow portion. Each axial frame member extends in an axial direction from a crown of the inflow portion to at least a crown of the outflow portion. Each axial frame member has a first end adjacent to the crown of the inflow portion, the first end having a reduced width relative to a width of a length of the axial frame member between the first end and the crown of the outflow portion.
Systems and methods for programming an implantable medical device comprising a simulated environment with at least one lead having a plurality of electrodes, computing hardware of at least one processor and a memory operably coupled to the at least one processor, and instructions that, when executed on the computing hardware, cause the computing hardware to implement a training sub-system configured to conduct a brain sense survey using the simulated environment, develop at least one machine learning model based on the brain sense survey, apply the at least one machine learning model to in-vivo patient data to determine at least one predicted electrode from the plurality of electrodes relative to an oscillatory source, visualize the at least one predicted electrode, and program a medical device based on the at least one predicted electrode.
A medical device having a motion sensor is configured to sense a motion signal, generate ventricular pacing pulses in a non-atrial tracking ventricular pacing mode and detect atrial event signals from the motion signal during the non-atrial tracking ventricular pacing mode. The medical device may be configured to determine atrial event intervals from the detected atrial event signals, determine a frequency distribution of the determined atrial event intervals and determine an atrial rate based on the frequency distribution of the detected atrial event intervals.
Systems, devices, and techniques are described for analyzing evoked compound action potentials (ECAP) signals to assess the effect of a delivered electrical stimulation signal. In one example, a system includes processing circuitry configured to receive ECAP information representative of an ECAP signal sensed by sensing circuitry, and determine, based on the ECAP information, that the ECAP signal includes at least one of an N2 peak, P3 peak, or N3 peak. The processing circuitry may then control delivery of electrical stimulation based on at least one of the N2 peak, P3 peak, or N3 peak.
A medical device, such as an extra-cardiovascular implantable cardioverter defibrillator (ICD), senses R-waves from a first cardiac electrical signal by a first sensing channel and stores a time segment of a second cardiac electrical signal acquired by a second sensing channel in response to each sensed R-wave. The ICD determines morphology match scores from the stored time segments of the second cardiac electrical signal and, based on the morphology match scores, withholds detection of a tachyarrhythmia episode. In some examples, the ICD detects T-wave oversensing based on the morphology match scores and withholds detection of a tachyarrhythmia episode in response to detecting the T-wave oversensing.
An implantable pump configured to enable tuning of a delivery velocity of a fixed quantity of medicament. The implantable pump including a pump, an accumulator and a valve configured to enable tuning of a delivery velocity of a fixed quantity of medicament, wherein operating the pump with the valve continuously in the open state enables a steady-state delivery of medicament at a first velocity, and wherein closing of the valve enables the pump to at least partially fill the accumulator and subsequent opening of the valve enables the at least partially filled accumulator to dispense medicament, thereby delivering a bolus of medicament at a second velocity, wherein the second velocity is greater than the first velocity.
Evaluating a cardiac lesion formed by an ablation procedure, by receiving, by processing circuitry and following conclusion of delivery of ablation energy, a bioelectrical signal from an electrode proximate to a target location of cardiac tissue for the cardiac lesion; determining, by the processing circuitry, one or more characteristics of the received bioelectrical signal in a frequency band of the received bioelectrical signal; and estimating, by the processing circuitry, an efficacy of the cardiac lesion based on a comparison of the determined amplitude of the bioelectrical signal and a threshold amplitude.
A sinus dilation instrument useful with a navigation system and including a handle, a rigid probe, a balloon, and an identifier device. The probe extends from the handle, forms a curved segment, and carries the balloon. The identifier device is programmed to generate a signal indicative of an instrument identification assigned to the instrument, and is a frontal, maxillary or sphenoid sinus instrument. The signal is formatted to be recognized by an IGS. Once connected, the IGS recognizes the instrument and can retrieve information indicative of a spatial location of the balloon, for example via an instrument tracking device. A surgeon can “plug and play” the sinus dilation instrument with the IGS to perform a procedure.
A61M 29/02 - Inflatable dilators; Dilators made of swellable materials
A61B 17/24 - Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
A61B 34/20 - Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
A61B 90/90 - Identification means for patients or instruments, e.g. tags
A61B 90/98 - Identification means for patients or instruments, e.g. tags using electromagnetic means, e.g. transponders
72.
CONTROLLING COMMUNICATION BETWEEN DEVICES OF A WIRELESS BODY AREA NETWORK FOR A MEDICAL DEVICE SYSTEM
Disclosed are methods and corresponding systems and devices for controlling which communication interface is used for communication in a wireless body area network of medical devices. In some aspects, a security level for data to be transmitted from a first device to a second device is determined. The first device includes a first communication interface and a second communication interface. Signals communicated over the second communication interface (e.g., a near-field communication interface) have a shorter range compared to the first communication interface (e.g., a far-field communication interface). The data is transmitted using the second communication interface based on determining that the security level for the data is higher than that associated with the first communication interface. In some instances, transmission of the data involves switching to the second communication interface after establishing an initial communication channel using the first communication interface.
An endovascular stent graft. The endovascular stent graft includes a body including a gate having an internal surface, a joining liner joined to the internal surface of the gate with a joint and having a bunched state and a crumpled state, and an implant at least partially disposed within the joining liner and having a radially compressed state and a radially expanded state. The implant in the radially expanded state exerts a radial force on the joining liner to maintain the joining liner in the crumpled state.
Disclosed herein are systems and methods for graft delivery with accurate dispensing. For example, a device for delivering graft material to a target site includes an actuation mechanism and a tube. The tube defines a lumen and an open end and is configured to receive graft material through the open end. The tube includes a pressure relief opening and a dosage window. The pressure relief opening is disposed in a wall of the tube, defining a pressure chamber between the open end and the pressure relief opening. The device further includes a plunger positioned within the lumen of the tube and coupled to the actuation mechanism such that at least a portion of the plunger (or the actuation mechanism) is visible through the dosage window. The actuation mechanism is configured to advance the plunger toward the open end to deliver graft material through the open end.
Evaluating a cardiac lesion formed by an ablation procedure, by receiving, by processing circuitry and following conclusion of delivery of ablation energy, a bioelectrical signal from an electrode proximate to a target location of cardiac tissue for the cardiac lesion; determining, by the processing circuitry, one or more characteristics of the received bioelectrical signal in a frequency band of the received bioelectrical signal; and estimating, by the processing circuitry, an efficacy of the cardiac lesion based on a comparison of the determined amplitude of the bioelectrical signal and a threshold amplitude.
A61B 18/00 - Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
76.
TECHNIQUES FOR IMPROVING EFFICIENCY OF DETECTION, COMMUNICATION, AND SECONDARY EVALUATION OF HEALTH EVENTS
Techniques are described for initiating a change to rules used by a medical device to identify a plurality of episodes based on a determination that an amount of the plurality of episodes classified as a classification for which transmission of the episode data from the medical device to the computing device was unnecessary satisfies at least one criterion.
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
In some embodiments, a bone implant for percutaneous use is provided. The bone implant comprises a head, a body adjacent to the head and a tip opposite the head. At least the head, body or tip is configured to contact bone. An expandable member contacts at least one of the head, tip or body and is movable from an unexpanded configuration to an expanded configuration when deployed at a bone implant site. In some embodiments, a system for percutaneous bone harvesting is provided.
Devices, systems, and techniques are disclosed for determining the likelihood that a cardiac event will self-terminate. An example technique includes determining, by processing circuitry and based on current sensed physiological parameters of a patient, that a cardiac event is occurring in the patient. The example technique includes determining, by the processing circuitry- and based on the current sensed physiological parameters of the patient, that the cardiac event is unlikely to self-terminate within a predetermined period of time. The example technique includes, in response to determining that the cardiac event is unlikely- to self-terminate, deliver therapy to the patient or issue an alert.
A61M 5/00 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
A61N 1/365 - Heart stimulators controlled by a physiological parameter, e.g. by heart potential
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
G16H 40/00 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
G16H 50/00 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
A61N 1/36 - Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
A method comprises applying, by processing circuitry of a system comprising a medical device, an ensemble of classifiers to episode data for a ventricular tachyarrhythmia episode detected by the medical device based on electrocardiogram sensed by the medical device. The method further comprises classifying, by the processing circuitry, the ventricular tachyarrhythmia episode as one of a plurality of classifications based on the application of the ensemble of classifiers to the episode data, wherein the plurality of classifications include two or more of noise, oversensing, supraventricular tachycardia, polymorphic ventricular tachycardia, monomorphic ventricular tachycardia, and ventricular fibrillation.
A system comprising processing circuitry configured to receive a wirelessly- transmitted messages from a patient or responder via one of their devices, the messages indicating a verified connection with that patient or responder device and a current location of the patient. After a number of messages, the processing circuitry generates an activity profile for the patient or responder such that in response to a next message, the processing circuitry is configured to determine a level of responsiveness to attribute to the patient or responder and coordinate an emergency response to the patient's current location based on the level of responsiveness.
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
81.
SURGICAL ABLATION TOOLS AND METHODS FOR USING THE SAME
A surgical tool for ablating anatomical tissue according to at least one embodiment of the present disclose includes: a distal tip; a first cylindrical tube connected to the distal tip; a second cylindrical tube that at least partially overlaps the first cylindrical tube in a first direction; and a J-shaped stylet disposed in an interior of the surgical tool, the J- shaped stylet capable of being removed from the interior of the surgical tool.
Various embodiments of a feedthrough assembly are disclosed. The assembly includes a header and a test fanout layer electrically connected to the header. A first major surface of the test fanout layer faces an inner surface of the header. The assembly further includes a test via extending between the first major surface and a second major surface of the test fanout layer, and a test pad disposed on the first major surface of the test fanout layer and electrically connected to the test via. At least a portion of the test pad is disposed between the outer surface of the header and a perimeter of the test fanout layer as viewed in a plane parallel to the first major surface of the test fanout layer such that the at least a portion of the test pad is exposed.
Disclosed herein are systems and methods for graft delivery with accurate dispensing. For example, a device (100) for delivering graft material to a target site includes an actuation mechanism (18) and a tube (200). The tube defines a lumen (40) and an open end (50) and is configured to receive graft material through the open end. The tube includes a pressure relief opening (44) and a dosage window (46). The pressure relief opening is disposed in a wall of the tube, defining a pressure chamber (47) between the open end and the pressure relief opening. The device further includes a plunger (210) positioned within the lumen of the tube and coupled to the actuation mechanism such that at least a portion of the plunger (or the actuation mechanism) is visible through the dosage window. The actuation mechanism is configured to advance the plunger toward the open end to deliver graft material through the open end.
A method for determining a depth of discharge of an electrochemical cell includes (i)) providing one or more alkaline electrochemical cells comprising Ag2O—Zn; (ii) applying a varying voltage potential to the one or more alkaline electrochemical cells, (iii) measuring an output current response of the one or more alkaline electrochemical cells, the output current response comprising a phase response as a function of frequency; and (iv) determining a depth of discharge of the one or more alkaline electrochemical cells based on a linear relationship of the depth of discharge with the phase response.
G01R 31/392 - Determining battery ageing or deterioration, e.g. state of health
G01R 31/378 - Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC] specially adapted for the type of battery or accumulator
G01R 31/387 - Determining ampere-hour charge capacity or SoC
G01R 31/36 - Arrangements for testing, measuring or monitoring the electrical condition of accumulators or electric batteries, e.g. capacity or state of charge [SoC]
G01R 31/389 - Measuring internal impedance, internal conductance or related variables
85.
DETECTION OF UNINTENTIONAL AND INTENTIONAL BODY SIGNALS TO CONTROL DEVICE STIMULATION
An implantable tibial nerve electrical stimulation therapy device, system and method configured to detect unintentional and intentional body signals to control and modify the electrical stimulation therapy, thereby enabling selective pausing of electrical stimulation therapy and increase/decrease in amplitude or frequency of the electrical stimulation therapy for improved safety, comfort and effective therapy.
An implantable medical system may provide atrioventricular synchronous pacing using the ventricular septal wall. The system may include a ventricular electrode coupled to an intracardiac housing or a first medical lead implantable in the ventricular septal wall of the patient's heart to deliver cardiac therapy to or sense electrical activity of the left ventricle of the patient's heart and a right atrial electrode coupled to a leadlet or second medical lead to deliver cardiac therapy to or sense electrical activity of the right atrium of the patient's heart. A right ventricular electrode may be coupled to the intracardiac housing or the first medical lead and implantable in the ventricular septal wall of the patient's heart to deliver cardiac therapy to or sense electrical activity of the right ventricle of the patient's heart.
A61N 1/368 - Heart stimulators controlled by a physiological parameter, e.g. by heart potential comprising more than one electrode co-operating with different heart regions
A61N 1/375 - Constructional arrangements, e.g. casings
A61N 1/05 - Electrodes for implantation or insertion into the body, e.g. heart electrode
87.
SURGICAL ABLATION TOOLS AND METHODS FOR USING THE SAME
A surgical tool for ablating anatomical tissue according to at least one embodiment of the present disclose includes: a distal tip; a first cylindrical tube connected to the distal tip; a second cylindrical tube that at least partially overlaps the first cylindrical tube in a first direction; and a J-shaped stylet disposed in an interior of the surgical tool, the J-shaped stylet capable of being removed from the interior of the surgical tool.
A tool includes a handle, a plunger actuator proximate the handle, a shaft extending from the handle, a plunger, an engagement mechanism. The shaft includes a proximal end and a distal end, and the shaft defines a channel extending along a length of the shaft. A first actuation of the plunger actuator causes the plunger to translate along the length of the shaft in a distal direction. A second actuation of the plunger actuator causes the plunger to translate along the length of the shaft in a proximal direction. The engagement mechanism is disposed on the distal end and is configured to engage an implantable medical device, and release the implantable medical device in response to the plunger exerting a contact force on the implantable medical device exceeding a reaction force of the engagement mechanism when the plunger translates along the length of the shaft in the distal direction.
Aspects of the present disclosure are directed to an implantable medical device including a housing containing components therein configured for delivering neurostimulation therapy, and an anchoring feature included with the housing. The implantable medical device also includes a lead having an electrode. In one aspect, the implantable medical device may include a guidewire passageway configured to allow the lead of implantable medical device to be introduced over a guidewire.
Disclosed are methods and corresponding systems and devices for providing an estimation model for use with one or more instances of a particular sensor. In some aspects, an estimation model usable for estimating a value of a physiological condition is determined based at least in part on simulated measurements. The simulated measurements are generated for a first sensor, through applying a translation model to convert historical measurements associated with a second sensor into measurements that would have been produced by the first sensor. The second sensor has a different design or configuration than the first sensor. The historical measurements represent changes in the physiological condition as observed by different instances of the second sensor. The estimation model can be made available to one or more electronic devices, including at least one device configured to apply the estimation model to a measurement from a corresponding instance of the first sensor.
G16H 50/50 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G06F 18/214 - Generating training patterns; Bootstrap methods, e.g. bagging or boosting
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
91.
GLUCOSE MANAGEMENT RECOMMENDATIONS BASED ON NUTRITIONAL INFORMATION
Techniques disclosed herein relate to glucose management recommendations based on nutritional information. In some embodiments, the techniques may involve obtaining user input that includes textual input indicating quantitative information for a food item. The techniques may also involve determining, based on the quantitative information for the food item, nutritional information for the food item, where the quantitative information for the food item is different from the nutritional information for the food item. The techniques may further involve generating, based on the nutritional information, a glucose management recommendation.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
A delivery system for delivering a prosthesis includes a spindle for securing a stent to a shaft. The spindle includes at least one pocket for receiving a paddle of the stent. The delivery system also includes at least one sensor positioned within the at least one pocket and configured to detect a presence of the paddle relative to the at least one pocket.
A method for deploying a stent device having a main body, a proximal coupling, and a distal coupling. The method includes extending a first guidewire in an aorta, extending a second guidewire in a brachiocephalic artery, and extending a third guidewire in an aortic branch vessel. The method further includes tracking the stent device along the first, second, and third guidewires. During the tracking step, the first guidewire extends through the main body, the second guidewire extends through the proximal coupling, and the third guidewire extends through the distal coupling. The method also includes deploying the main body within the aorta with the proximal coupling aligning with the brachiocephalic artery and the distal coupling aligning with the aortic branch vessel.
In some examples, a catheter may include an elongate body and a push assembly. The elongate body may include an inner liner defining an entry port into a lumen defined by the elongate body, and an outer jacket. The push assembly may an anchor member positioned at a distal end of an elongate member. Distal to a proximal end of the elongate body, a first portion of the push assembly, comprising the anchor member, may be positioned between a portion of the inner liner and a portion of the outer jacket. The anchor member may extend only partially around an outer perimeter of the inner liner when the catheter is assembled. Proximal to the proximal end of the elongate body, a second portion of the push assembly, proximal to the first portion, may be positioned outside of the outer jacket and the inner liner.
A61M 25/06 - Body-piercing guide needles or the like
A61F 2/966 - Instruments specially adapted for placement or removal of stents or stent-grafts having an outer sleeve with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
In some embodiments, a bone implant for percutaneous use is provided. The bone implant comprises a head, a body adjacent to the head and a tip opposite the head. At least the head, body or tip is configured to contact bone. An expandable member contacts at least one of the head, tip or body and is movable from an unexpanded configuration to an expanded configuration when deployed at a bone implant site. In some embodiments, a system for percutaneous bone harvesting is provided.
An example system includes communication circuitry configured to communicate with a medical device system, memory communicatively coupled to the communication circuitry and being configured to store an identifier associated with the medical device system and a subscription service level of a patient, and processing circuitry communicatively coupled to the communication circuitry and the memory. The processing circuitry is configured to control the communication circuitry to receive a communication associated with the medical device system, the communication comprising an identifier. The processing circuitry is configured to determine, based on the identifier, the subscription service level of the patient. The processing circuitry is configured to generate, based on the subscription service level of the patient, a configuration message and control the communication circuitry to transmit the configuration message to the medical device system.
A tool includes a handle, a plunger actuator proximate the handle (42), a shaft (44) extending from the handle, a plunger (52), an engagement mechanism. The shaft includes a proximal end and a distal end, and the shaft defines a channel extending along a length of the shaft. A first actuation of the plunger actuator causes the plunger to translate along the length of the shaft in a distal direction. A second actuation of the plunger actuator causes the plunger to translate along the length of the shaft in a proximal direction. The engagement mechanism is disposed on the distal end and is configured to engage an implantable medical device (16), and release the implantable medical device in response to the plunger exerting a contact force on the implantable medical device exceeding a reaction force of the engagement mechanism when the plunger translates along the length of the shaft in the distal direction.
A medical includes a first device configured to receive data from a medical device, determine based on the data that the patient is experiencing an acute health event, and in response to determining that the patient is experiencing the acute heath event, broadcast a message to a plurality of computing devices. The plurality of devices includes a second device configured to receive the message from the first device and establish a communication session with the first device in response to receiving the message.
G16H 15/00 - ICT specially adapted for medical reports, e.g. generation or transmission thereof
A61B 5/00 - Measuring for diagnostic purposes ; Identification of persons
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 80/00 - ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
H04Q 11/00 - Selecting arrangements for multiplex systems
G16H 10/65 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records stored on portable record carriers, e.g. on smartcards, RFID tags or CD
G16H 20/00 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
99.
DYNAMIC CONFIGURATION OF MEDICAL DEVICES AND SYSTEMS USING JURISDICTIONAL CONSTRAINTS FOR ALGORITHM SELECTION
This disclosure is directed to medical systems and techniques for dynamic configuration of medical devices. In one example, a method is configured to access a data structure comprising an algorithm for health event detection in patient data generated by at least one of a medical device of the patient or a personal device of the patient based on a usage scenario. An association of the algorithm and the usage scenario in the data structure indicates that use of the algorithm for the usage scenario complies with one or more jurisdictional requirements.
G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 40/20 - ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
42 - Scientific, technological and industrial services, research and design
Goods & Services
Software as a service (SAAS) services featuring software for analyzing, detecting, diagnosing, managing, processing, reporting, monitoring, tracking, transmitting and displaying medical and health data; software as a service (SAAS) services featuring software used to program, operate and to connect medical devices and medical imaging devices; software as a service (SAAS) services featuring software used for diabetes management; software as a service (SAAS) services featuring computer software for creating, offering, hosting and delivering online demonstrations and presentations in the field of medical devices and surgical procedures; software as a service (SAAS) services featuring software used for monitoring, tracking, managing and conducting healthcare, surgical procedures and medical treatment.
